UK Pharma Chiefs To Helm Brexit Steering Committee
Executive Summary
Sir Andrew Witty and Pascal Soriot, CEOs of GlaxoSmithKline and AstraZeneca, respectively, are to co-chair a new steering group along with George Freeman, the UK's life sciences minister. The group will address the challenges posed to the sector by the UK's decision to withdraw from the EU.
You may also be interested in...
New Barrier For UK’s Brexit Plans; Industry Looks For Potential Opportunities
The UK Parliament may get to vote on the terms of the country’s departure from the EU if an important legal decision handed down Nov. 3 is upheld. Industry is looking at potential opportunities from Brexit as the next round of talks with the government nears.
Spanner In Works For UK Gvn’t’s Brexit Plans; Industry Looks To Ongoing Talks with Ministers
Parliament may get to vote on the terms of the UK’s departure from the EU if an important legal decision handed down today is upheld. Industry has its eye on ongoing talks with the government.
Spanner In Works For UK Gov’t’s Brexit Plans; Industry Looks To Ongoing Talks With Ministers
Parliament may get to vote on the terms of the UK’s departure from the EU if an important legal decision handed down today is upheld. Industry has its eye on ongoing talks with the government.